Measuring height and weight as part of routine mammographic screening for breast cancer

Research output: Contribution to journalArticle

Abstract

Objectives Body mass index is a strong predictor of post-menopausal breast cancer risk and (negatively) confounds the association between mammographic breast density and breast cancer risk; however, height and weight are not typically measured as part of routine mammographic screening. This study piloted voluntary height and weight measurement within the BreastScreen Western Australia (WA) programme, and assessed trial participation. Methods From February 2016 to January 2018, 204,429 women attending BreastScreen WA were invited to have their height and weight measured and recorded as part of their routine screening mammogram. Descriptive data analysis was used to assess pilot participation rates by available screening data. Results Of the 204,429 patients who attended BreastScreen WA during the pilot, 76.35% (156,072) agreed to have their height and weight measured. Pilot participation rates were significantly lower in those patients with disabilities (RR: 0.626; 95% CI: 0.600, 0.653), those who spoke a language other than English at home (RR: 0.876; 95% CI: 0.867, 0.885), and those who identified as Aboriginal and Torres Strait Islander (RR: 0.829; 95% CI: 0.807, 0.852). Pilot participation decreased over time from 88.9% in the first three months to 55.5% in the last month, due to lessening of support from BreastScreen staff. Conclusion Measuring height and weight at the time of routine mammographic screening is feasible, although logistical issues, particularly the added time/effort required of support staff, should be considered. BreastScreen WA has since decided to collect voluntary self-reported height and weight data as routine screening policy.

Original languageEnglish
Number of pages8
JournalJournal of Medical Screening
DOIs
Publication statusE-pub ahead of print - 9 Jul 2019

Cite this

@article{787421a8779b4feb8bc3ff8eb0ddf894,
title = "Measuring height and weight as part of routine mammographic screening for breast cancer",
abstract = "Objectives Body mass index is a strong predictor of post-menopausal breast cancer risk and (negatively) confounds the association between mammographic breast density and breast cancer risk; however, height and weight are not typically measured as part of routine mammographic screening. This study piloted voluntary height and weight measurement within the BreastScreen Western Australia (WA) programme, and assessed trial participation. Methods From February 2016 to January 2018, 204,429 women attending BreastScreen WA were invited to have their height and weight measured and recorded as part of their routine screening mammogram. Descriptive data analysis was used to assess pilot participation rates by available screening data. Results Of the 204,429 patients who attended BreastScreen WA during the pilot, 76.35{\%} (156,072) agreed to have their height and weight measured. Pilot participation rates were significantly lower in those patients with disabilities (RR: 0.626; 95{\%} CI: 0.600, 0.653), those who spoke a language other than English at home (RR: 0.876; 95{\%} CI: 0.867, 0.885), and those who identified as Aboriginal and Torres Strait Islander (RR: 0.829; 95{\%} CI: 0.807, 0.852). Pilot participation decreased over time from 88.9{\%} in the first three months to 55.5{\%} in the last month, due to lessening of support from BreastScreen staff. Conclusion Measuring height and weight at the time of routine mammographic screening is feasible, although logistical issues, particularly the added time/effort required of support staff, should be considered. BreastScreen WA has since decided to collect voluntary self-reported height and weight data as routine screening policy.",
keywords = "Mammographic screening, height, weight, body mass index, participation, breast cancer, SIZE, DENSITY, RISK",
author = "Ellie Darcey and Ravi Ambati and Helen Lund and Andrew Redfern and Christobel Saunders and Sandra Thompson and Elizabeth Wylie and Jennifer Stone",
year = "2019",
month = "7",
day = "9",
doi = "10.1177/0969141319860873",
language = "English",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Measuring height and weight as part of routine mammographic screening for breast cancer

AU - Darcey, Ellie

AU - Ambati, Ravi

AU - Lund, Helen

AU - Redfern, Andrew

AU - Saunders, Christobel

AU - Thompson, Sandra

AU - Wylie, Elizabeth

AU - Stone, Jennifer

PY - 2019/7/9

Y1 - 2019/7/9

N2 - Objectives Body mass index is a strong predictor of post-menopausal breast cancer risk and (negatively) confounds the association between mammographic breast density and breast cancer risk; however, height and weight are not typically measured as part of routine mammographic screening. This study piloted voluntary height and weight measurement within the BreastScreen Western Australia (WA) programme, and assessed trial participation. Methods From February 2016 to January 2018, 204,429 women attending BreastScreen WA were invited to have their height and weight measured and recorded as part of their routine screening mammogram. Descriptive data analysis was used to assess pilot participation rates by available screening data. Results Of the 204,429 patients who attended BreastScreen WA during the pilot, 76.35% (156,072) agreed to have their height and weight measured. Pilot participation rates were significantly lower in those patients with disabilities (RR: 0.626; 95% CI: 0.600, 0.653), those who spoke a language other than English at home (RR: 0.876; 95% CI: 0.867, 0.885), and those who identified as Aboriginal and Torres Strait Islander (RR: 0.829; 95% CI: 0.807, 0.852). Pilot participation decreased over time from 88.9% in the first three months to 55.5% in the last month, due to lessening of support from BreastScreen staff. Conclusion Measuring height and weight at the time of routine mammographic screening is feasible, although logistical issues, particularly the added time/effort required of support staff, should be considered. BreastScreen WA has since decided to collect voluntary self-reported height and weight data as routine screening policy.

AB - Objectives Body mass index is a strong predictor of post-menopausal breast cancer risk and (negatively) confounds the association between mammographic breast density and breast cancer risk; however, height and weight are not typically measured as part of routine mammographic screening. This study piloted voluntary height and weight measurement within the BreastScreen Western Australia (WA) programme, and assessed trial participation. Methods From February 2016 to January 2018, 204,429 women attending BreastScreen WA were invited to have their height and weight measured and recorded as part of their routine screening mammogram. Descriptive data analysis was used to assess pilot participation rates by available screening data. Results Of the 204,429 patients who attended BreastScreen WA during the pilot, 76.35% (156,072) agreed to have their height and weight measured. Pilot participation rates were significantly lower in those patients with disabilities (RR: 0.626; 95% CI: 0.600, 0.653), those who spoke a language other than English at home (RR: 0.876; 95% CI: 0.867, 0.885), and those who identified as Aboriginal and Torres Strait Islander (RR: 0.829; 95% CI: 0.807, 0.852). Pilot participation decreased over time from 88.9% in the first three months to 55.5% in the last month, due to lessening of support from BreastScreen staff. Conclusion Measuring height and weight at the time of routine mammographic screening is feasible, although logistical issues, particularly the added time/effort required of support staff, should be considered. BreastScreen WA has since decided to collect voluntary self-reported height and weight data as routine screening policy.

KW - Mammographic screening

KW - height

KW - weight

KW - body mass index

KW - participation

KW - breast cancer

KW - SIZE

KW - DENSITY

KW - RISK

U2 - 10.1177/0969141319860873

DO - 10.1177/0969141319860873

M3 - Article

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

ER -